# FDA Inspection 621071 - SPI Pharma, SAS - September 29, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-sas/a58f232a-dd26-4b08-ac2a-d1e95e43b9ff
Source feed: FDA_Inspections

> FDA Inspection 621071 for SPI Pharma, SAS on September 29, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 621071
- Company Name: SPI Pharma, SAS
- Inspection Date: 2009-09-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273714 - 2024-04-26](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-sas/d858a97a-f3ad-4dbb-8197-924c2b9cf511)
- [FDA Inspection 1125749 - 2018-06-29](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-sas/b0589528-66eb-498f-a0b2-cb46ab2e819f)
- [FDA Inspection 968552 - 2016-02-12](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-sas/007c79ec-6a19-424f-8860-c4aa2acd08f3)
- [FDA Inspection 826851 - 2013-02-14](https://www.globalkeysolutions.net/records/fda_inspections/spi-pharma-sas/c07ca6a7-84b9-4b3d-aeac-eae5c00d6a6f)

Company: https://www.globalkeysolutions.net/companies/spi-pharma-sas/ec8fe21b-d621-4f9c-86ff-0816fa764ec5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c